
If it sounds too good to be true, then you probably shouldn’t buy it.
That’s the lesson from a recent Federal Trade Commission action against telehealth company, NextMed.

If it sounds too good to be true, then you probably shouldn’t buy it.
That’s the lesson from a recent Federal Trade Commission action against telehealth company, NextMed.